Related Experiment Video
Updated: Jan 18, 2026

06:13
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
1.6K
Sleep coach intervention for adolescents with type 1 diabetes: Rationale and trial design.
Sarah S Jaser1, Jill Simmons1, Lauren L Milner1
1Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Contemporary Clinical Trials
|September 12, 2025
Summary
A new sleep coaching intervention for adolescents with type 1 diabetes (T1D) may improve sleep duration and glycemic control. This approach aims to enhance diabetes management and reduce health complication risks in young individuals.
Area of Science:
- Pediatric Endocrinology
- Behavioral Science
- Sleep Medicine
Background:
- Most adolescents with type 1 diabetes (T1D) do not meet glycemic targets, increasing complication risks.
- Poor sleep negatively impacts insulin sensitivity and executive function, hindering T1D management.
- Novel interventions are needed to improve diabetes care in adolescents.
Purpose of the Study:
- To evaluate a sleep-promoting behavioral intervention (Sleep Coach) for adolescents with T1D.
- To assess the intervention's effects on sleep duration, variability, executive function, and glycemic outcomes.
- To determine if individualized sleep coaching improves diabetes management.
Main Methods:
- Randomized controlled trial with 150 adolescents (11-17 years) with T1D.
- Intervention group received sleep coaching; control group received enhanced usual care.
- Primary outcomes (sleep duration/timing) and secondary outcomes (executive function, glycemic control) assessed over 12 months.
Main Results:
- Adolescents in the Sleep Coach group are hypothesized to show significantly longer sleep duration and reduced sleep variability.
- The intervention is expected to positively impact executive function and glycemic control (hemoglobin A1c, Time in Range).
Conclusions:
- The Sleep Coach intervention shows potential for improving cognitive and glycemic outcomes in adolescents with T1D.
- This remotely deliverable behavioral intervention could be widely disseminated.
- Improved sleep may be a key factor in better diabetes management for adolescents.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Insulin: Dosing Regimen and Adverse Effects
695
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
695
Diabetes: Management and Pharmacotherapy
870
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
870

